IP Library Patent Application 11722459
Patent Application
App. No. 11/722,459

USE OF BOTULINUM TOXIN FOR PORLONGED LOCAL DESENSITIZATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/722,459
Abstract

The invention concerns the use or a fragment of botulinum toxin having said toxin activity for preparing a medicine for reversibly desensitizing an area of the skin, said skin area being designed to receive injections. Said injections can be related, for example, to repeated delivery of insulin, growth hormones or other medicines in injectable form.

Claims (10)

1 . A method for reversibly desensitizing an area of skin subjected to repeated, repetitive or specific induced pain caused by repeated punctures or injections, comprising applying a medicament comprising botulinum toxin or a fragment of botulinum toxin possessing the activity of said toxin.

2 . The method of claim 1 , wherein the pain is caused by the administration of insulin, growth hormone, peptides in the form of autogel chemotherapy agents or other medicaments in injectable form or also caused by punctures for blood collections for measuring blood glucose level.

3 . The method of claim 1 or 2 , wherein the botulinum toxin is a botulinum toxins of type A, B, C, D, E, F or G.

4 . The method of claim 3 , wherein the botulinum toxin used is a botulinum toxins of type A, B or F.

5 . The method of claim 4 , wherein the botulinum toxin used is a botulinum toxin of type A or B.

6 . The method of claim 5 , wherein the botulinum toxin used is a botulinum toxin of type A.

7 . The method of claim 1 , wherein the medicament is administered by intradermal, transdermal or subcutaneous route.

8 . The method of claim 1 , wherein the desensitization caused lasts at least one month.

9 . The method of claim 8 , wherein the desensitization caused lasts at least two months.

10 . The method of claim 9 , wherein the desensitization caused lasts at least three months.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME PREVIOUSLY RECORDED ON REEL 296336 FRAME 0777. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 5, 2016
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
To: IPSEN PHARMA S.A.S.
Reel/Frame 037430/0194 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS PREVIOUSLY RECORDED ON REEL 023034 FRAME 0251. ASSIGNOR(S) HEREBY CONFIRMS THE ADDRESS SHOULD BE 65 QUAI GEORGES GORSE, 92100 BOULOGNE-BILLANCOURT, FRANCE. Recorded Jan 16, 2013
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S.)
To: IPSEN PHARMA S.A.S.
Reel/Frame 029636/0777 →
CHANGE OF NAME Recorded Jul 31, 2009
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTIFIQUES (S.C.R.A.S.)
To: IPSEN PHARMA S.A.S.
Reel/Frame 023034/0251 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2007
From: CHERIF-CHEIKH, ROLAND
To: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES
Reel/Frame 019465/0327 →